Red Herring Research

NIRS: Emerging Living Tissue Monitors
TABLE OF CONTENTS

View Shopping Cart
Checkout Now

The market for clinical Near Infrared Spectroscopy (NIRS) devices, as “living tissue” monitors, extends beyond the wide range of conventional hospital and surgery settings to encompass emergency transport, pharmacy sales for at-home use, veterinary care, military field care, laboratory research, athletic performance training and biometric pass coding. Clinical NIRS devices have the potential to change the way medicine is done by combining an early warning system and extreme sensitivity to critical changes in physiological status. As an emerging technology on the cusp of a major breakthrough, NIRS is poised to become a dominant player the medical device and single-use disposables market place; currently, it has the potential for $2-3 billion in device sales and $12 billion annually in consumables sales.

Price: $995.00

Enlarge Image (click here)

Details:

	76 pages
	Profiles on the Top 20 Emerging Private Companies and 12 key public companies.

TABLE OF CONTENTS

1. Introduction
The emerging NIRS technology market has the potential for $2-3 billion in device sales and $12 billion annually in consumables sales.

2. Key Issues
Whether living tissue NIRS continues as an emerging technology depends entirely upon resolving the unknown sample volume dilemma.

3. Emerging Technologies
There is a tremendous diversity in the size, shape, weight, capabilities, and functions of the clinical NIRS devices being manufactured.

4 Investment Opportunities
The greatest cost is in conducting the clinical trials needed to gain FDA medical device approval. Early stage VC investment in this sector is not really required

4.1 Public Companies

Leading global public companies
4.2 Private Company Profiles: 20 Leading global NIRS companies
4.3 Comparable Table: Spectroscopy technology companies – valuation
4.4 Financing Activity: Recent M&A activity
: Recent financings
5. Analysis & Conclusion The global opportunity, the flexibility in design of clinical NIRS devices and their overwhelming attributes, gives this sector tremendous appeal to enter several healthcare markets.: Key market opportunities
: Recent NIRS patents issued
Appendix Glossary of terms Early stage NIRS investor profiles NIRS patents pending (2004-2007) NIRS conferences NIRS related websites NIRS publications NIRS medical articles (2007)